Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Duquette

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
International MS Journal|June 16, 2005
Interferons in MS Treatment: report from the Canadian MS Forum symposium, 26-29 August 2004, Québec, CanadaPierre Duquette
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 19, 2012
Deaths and disability from natalizumab are no longer tolerable: YesPierre Duquette
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 10, 2010
Brain, cognition and MRI in MS: an ongoing refinement processCéline Jobin, Pierre Duquette
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
How safe is natalizumab during pregnancy?Pierre Duquette, Alexandre Prat
Frontiers in Neurology|August 22, 2022
Clinical insights on the spasticity-plus syndrome in multiple sclerosisKanza Alami Marrouni, Pierre Duquette
Neurology|November 23, 2005
Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosisChantale Auger, Jacques Montplaisir, Pierre Duquette
Archives of Physical Medicine and Rehabilitation|April 19, 2017
Path to Illness Intrusiveness: What Symptoms Affect the Life of People Living With Multiple Sclerosis?Vanessa Bouchard, Pierre Duquette, Nancy E Mayo
Caspian Journal of Internal Medicine|September 11, 2018
Impairment, disability and fatigue in multiple sclerosisShahnaz Shahrbanian, Pierre Duquette, Nancy E Mayo
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 10, 2015
Pain acts through fatigue to affect participation in individuals with multiple sclerosisShahnaz Shahrbanian, Pierre Duquette, Sara Ahmed, et al.
Clinical Immunology (Orlando, Fla.)|April 24, 2007
Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patientsAnnie Boucher, Marc Desforges, Pierre Duquette, et al.
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
International MS Journal|June 16, 2005
Interferons in MS Treatment: report from the Canadian MS Forum symposium, 26-29 August 2004, Québec, CanadaPierre Duquette
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 19, 2012
Deaths and disability from natalizumab are no longer tolerable: YesPierre Duquette
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 10, 2010
Brain, cognition and MRI in MS: an ongoing refinement processCéline Jobin, Pierre Duquette
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
How safe is natalizumab during pregnancy?Pierre Duquette, Alexandre Prat
Frontiers in Neurology|August 22, 2022
Clinical insights on the spasticity-plus syndrome in multiple sclerosisKanza Alami Marrouni, Pierre Duquette
Neurology|November 23, 2005
Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosisChantale Auger, Jacques Montplaisir, Pierre Duquette
Archives of Physical Medicine and Rehabilitation|April 19, 2017
Path to Illness Intrusiveness: What Symptoms Affect the Life of People Living With Multiple Sclerosis?Vanessa Bouchard, Pierre Duquette, Nancy E Mayo
Caspian Journal of Internal Medicine|September 11, 2018
Impairment, disability and fatigue in multiple sclerosisShahnaz Shahrbanian, Pierre Duquette, Nancy E Mayo
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 10, 2015
Pain acts through fatigue to affect participation in individuals with multiple sclerosisShahnaz Shahrbanian, Pierre Duquette, Sara Ahmed, et al.
Clinical Immunology (Orlando, Fla.)|April 24, 2007
Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patientsAnnie Boucher, Marc Desforges, Pierre Duquette, et al.
Pageof 17